Advertisement

Topics

Horizon Pharma plc Company Profile

10:43 EDT 18th June 2019 | BioPortfolio

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.


News Articles [1164 Associated News Articles listed on BioPortfolio]

Horizon Pharma announces positive results for teprotumumab

Ireland-based Horizon Pharma has announced positive top-line results from the Phase III confirmatory trial of teprotumumab in patients with active...Read More... The post Horizon Pharma announces posi...

Horizon Pharma plc to Present at the 37th Annual J.P. Morgan Healthcare Conference

Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the 37th Annual J.P. Morgan Healthcare Conference. Timothy P. Walbert, chairman, president a...

A new horizon

The future of AI in pharma and wider healthcare is unfolding right now – never has the crystal ball of science found itself so resolutely in the present. If we dare to glance at the horizon, how...

Horizon Pharma Sees Mid-2019 BLA For Tepro After Solid Phase III TED Data

Horizon Pharma is on track to file its top pipeline asset for regulatory approval this year after its Phase III...    

Horizon Pharma’s Thyroid Eye Disease Treatment Could Become a Blockbuster, Analyst Predicts

Ireland-based Horizon Pharma reported additional statistically significant secondary data from its positive Phase III study at a conference and plans to continue to share analysis at future medical co...

Horizon Pharma nets $328mm in public offering

Horizon Pharma PLC netted $327.7mm in a follow-on public offering of 14mm ordinary shares (including the overallotment) at $24.50. The company will use the proceeds (along with cash on hand) to repay ...

Horizon Pharma Announces FDA Approval to Expand the Age Range for RAVICTI

Horizon Pharma (NASDAQ:HZNP) today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for RAVICTI® (glycerol phenylb...

Horizon Pharma plc to Participate in Cowen and Company 39th Annual Health Care Conference

Horizon Pharma plc (Nasdaq: HZNP), today announced that the company will participate in the following conference in March: Cowen and Company 39th Annual Health Car...

Drugs and Medications [65 Associated Drugs and Medications listed on BioPortfolio]

Amlodipine besylate [new horizon rx group, llc]

These highlights do not include all the information needed to use AMLODIPINE BESYLATE safely and effectively. See full prescribing information for AMLODIPINE BESYLATE. AMLODIPINE BESYLATE (AMLODIPINE ...

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 1 mg

Urea [mayne pharma inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [aventis pharma ltd.]

NA

PubMed Articles [91 Associated PubMed Articles listed on BioPortfolio]

Decoding the Apparent Horizon: Coarse-Grained Holographic Entropy.

When a black hole forms from collapse in a holographic theory, the information in the black hole interior remains encoded in the boundary. We prove that the area of the black hole's apparent horizon i...

Intra-horizon differentiation of the bacterial community and its co-occurrence network in a typical Plinthic horizon.

Subsurface soil bacterial community composition and the controlling factors remain largely unknown, especially the micro-zone differentiation of community composition within a horizon. We studied a pl...

Physicians in the pharmaceutical industry: their roles, motivations, and perspectives.

Although physicians occupy a significant number of key positions in the pharmaceutical industry, practicing clinicians are often unaware of the variety of career paths within this industry, or of the ...

Establishing and Maintaining a Robust Sample Management System.

This paper has been written by the SLAS Sample Management Special Interest Group to serve as a guide to the best practices and methods in establishing and maintaining a high-quality sample management ...

Physiological impacts of Deepwater Horizon oil on fish.

An explosion on the Deepwater Horizon (DWH) oil rig in 2010 lead to the largest marine oil spill to occur in US history, resulting in significant impacts to the ecosystems and organisms in the Norther...

Clinical Trials [125 Associated Clinical Trials listed on BioPortfolio]

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

The purpose of this study is to evaluate the rhBMP-2/CRM/CD HORIZON® Spinal System as a method of facilitating spinal fusion in patients with degenerative disc disease.

HORIZON-PFT: Pivotal Fracture Trial

HORIZON-PFT (Pivotal Fracture Trial) will study the effect of zoledronic acid, given once per year, on the treatment of osteoporosis in women past menopause. Hip and vertebral fractures a...

"Efficacy of Hybrid Systems ("Topping Off") Versus Rigid Spinal Fusion in Lumbar Fusion Surgery: A Dual-center, Prospective, Randomized Pilot Study ("CD Horizon BalanC")"

Effectiveness of hybrid systems ("topping off") compared to rigid spondylodesis in fusion surgery of the lumbar spine: A prospective, randomized, bicentric pilot study ("CD HORIZON BalanC...

HORIZON CE Pivotal Study to Treat Abdominal Aortic Aneurysm

Clinical Investigation Design A prospective, open-label, non-randomized, interventional clinical study, sponsored by Endospan Ltd. Patients will be followed-up for five years. Investigati...

Double-Blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)

This extension study is designed to assess the long term safety and efficacy of zoledronic acid in postmenopausal women with osteoporosis who have participated in the CZOL446H2301 study (H...

Companies [854 Associated Companies listed on BioPortfolio]

Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering ...

WhiteWave Foods/Horizon Organic

Horizon is committed to providing great-tasting, organic dairy products that nourish families and build healthy foundations. Celebrating its 20th anniversary this year, Horizon is...

Horizon Organic

Horizon believes the choice for a healthy family and a healthy planet should be an easy one. Horizon offers a delicious variety of certified organic dairy products to satisfy a br...

Horizon BCBSNJ

Horizon believes the choice for a healthy family and a healthy planet should be an easy one. Horizon offers a delicious variety of certified organic dairy products to satisfy a br...

Horizon Blue Cross Blue Shield of New Jersey

Horizon Blue Cross Blue Shield of New Jersey, the state’s oldest and largest health insurer, is a not-for-profit health services corporation. Horizon BCBSNJ serves over 3.6 m...

More Information about "Horizon Pharma plc" on BioPortfolio

We have published hundreds of Horizon Pharma plc news stories on BioPortfolio along with dozens of Horizon Pharma plc Clinical Trials and PubMed Articles about Horizon Pharma plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Horizon Pharma plc Companies in our database. You can also find out about relevant Horizon Pharma plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record